Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (59 ops.)
Latest filing published 21 Sept 2026 for BridgeBio Pharma, Inc., €525k. Read the official filing
Filing timeline
BuySaleNeil Kumar
Insider track record
Disclosed buys
0
Disclosed sells
59
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Neil Kumar: trading record in brief
All filings by Neil Kumar on record concern BridgeBio Pharma, Inc., in the capacity of chief executive. Between 16 May 2021 and 17 September 2026, the trades on record add up to 86 filings.
Sales make up the whole of the open-market record (59 sales, €47.4M). The totals exclude 1 filing filed without an amount. Other entries cover 1 share grant and 25 option exercises. Since January 2026: no purchases and 40 sales on the market.
The record was last updated on 21 September 2026 with an open-market sale (€525k) in BridgeBio Pharma, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Neil Kumar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations86 total
8,721 shares@ US$69.0136Common StockSEC:0001470831-26-000897:0
1,279 shares@ US$69.5696Common StockSEC:0001470831-26-000897:1
8,100 shares@ US$83.85880.0042% mcap1.2% of flowCommon StockSEC:0001470831-26-000848:4
1,900 shares@ US$81.14940.0010% mcap0.3% of flowCommon StockSEC:0001470831-26-000848:0
14,602 shares@ US$82.99220.0075% mcap2.2% of flowCommon StockSEC:0001470831-26-000848:2
1,199 shares@ US$83.77320.0006% mcap0.2% of flowCommon StockSEC:0001470831-26-000848:3
1,800 shares@ US$84.68670.0009% mcap0.3% of flowCommon StockSEC:0001470831-26-000848:5
100 shares@ US$85.650.0001% mcap0.0% of flowCommon StockSEC:0001470831-26-000848:6
17,279 shares@ US$82.21040.0088% mcap2.5% of flowCommon StockSEC:0001470831-26-000848:1
33,544 sharesCommon StockSEC:0001470831-26-000836:0
19,599 sharesCommon StockSEC:0001470831-26-000836:1
11,554 sharesCommon StockSEC:0001470831-26-000836:2
6,520 sharesCommon StockSEC:0001470831-26-000836:3
36,237 shares@ US$79.860.019% mcap5.5% of flowCommon StockSEC:0001470831-26-000836:4
2,200 shares@ US$65.72020.0009% mcap0.4% of flowCommon StockSEC:0001470831-26-000523:0
1,429 shares@ US$66.7230.0006% mcap0.3% of flowCommon StockSEC:0001470831-26-000523:1
15,921 shares@ US$67.73780.0067% mcap3.0% of flowCommon StockSEC:0001470831-26-000523:2
450 shares@ US$68.26970.0002% mcap0.1% of flowCommon StockSEC:0001470831-26-000523:3
15,921 shares@ US$67.73770.0067% mcap3.0% of flowCommon StockSEC:0001470831-26-000523:6
7,147 shares@ US$67.1990.0030% mcap1.3% of flowCommon StockSEC:0001470831-26-000523:8
8,437 shares@ US$67.88480.0036% mcap1.6% of flowCommon StockSEC:0001470831-26-000523:9
4,416 shares@ US$68.95930.0019% mcap0.9% of flowCommon StockSEC:0001470831-26-000523:10
7,148 shares@ US$67.1990.0030% mcap1.3% of flowCommon StockSEC:0001470831-26-000523:11
4,415 shares@ US$68.95930.0019% mcap0.9% of flowCommon StockSEC:0001470831-26-000523:13
2,200 shares@ US$65.72020.0009% mcap0.4% of flowCommon StockSEC:0001470831-26-000523:4
25 of 86 declarations
